Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL)

Q: What does CUSIP 55083R104 represent in this 13F holders report?

CUSIP 55083R104 is the security identifier for LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share in Q2 2022?

72 institutional investors reported LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 55083R104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 19,277,111
Total 13F shares: 105,615,240
Share change: +6,151,912
Total reported value: $688,647,561
Put/Call ratio: 0%
Price per share: $6.52
Number of holders: 72
Value change: +$42,215,226
Number of buys: 36
Number of sells: 34

Quarterly Holders Quick Answers

What is CUSIP 55083R104?
CUSIP 55083R104 identifies LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 55083R104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MWG Management Ltd.	13F	Company	105%	20,162,332	$101,820,000	—	31 Mar 2022	13F
Apoletto Ltd	13F	Company	78%	15,093,969	$76,225,000	—	31 Mar 2022	13F
GSK plc	3/4/5	10%+ Owner	— class O/S missing	30,253,189	$68,977,271	—	21 Jun 2021	3/4/5
Foresite Capital Management IV, LLC	13F	Company	69%	13,282,181	$67,075,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	46%	8,778,702	$44,332,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	41%	7,809,490	$39,438,000	—	31 Mar 2022	13F
Alphabet Inc.	13F	Company	30%	5,865,125	$29,619,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	28%	5,493,922	$27,744,000	—	31 Mar 2022	13F
HSG Holding Ltd	13F	Company	16%	3,045,997	$15,382,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	13%	2,482,323	$12,536,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	9.8%	1,890,929	$9,549,000	—	31 Mar 2022	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	8.5%	1,647,882	$8,322,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	7.5%	1,454,233	$7,343,000	—	31 Mar 2022	13F
MIC Capital Management UK LLP	13F	Company	6.8%	1,320,000	$6,666,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	5.5%	1,052,410	$5,315,000	—	31 Mar 2022	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	5.2%	995,531	$5,027,000	—	31 Mar 2022	13F
BAILLIE GIFFORD & CO	13F	Company	4.1%	784,741	$3,963,000	—	31 Mar 2022	13F
Artal Group S.A.	13F	Company	3.6%	700,000	$3,535,000	—	31 Mar 2022	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	3.1%	588,235	$2,971,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	2.9%	553,800	$2,830,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	2.7%	518,404	$2,618,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	2.7%	513,200	$2,592,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	2.4%	453,144	$2,289,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	2%	390,166	$1,970,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	1.9%	358,040	$1,808,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	1.7%	323,246	$1,632,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.5%	281,855	$1,423,000	—	31 Mar 2022	13F
Adero Partners, LLC	13F	Company	1.3%	253,512	$1,280,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	1.3%	249,038	$1,258,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	1%	201,793	$1,019,000	—	31 Mar 2022	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1%	192,617	$975,000	—	31 Mar 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.95%	182,822	$960,734	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.97%	186,837	$943,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.97%	186,356	$941,000	—	31 Mar 2022	13F
TD ASSET MANAGEMENT INC	13F	Company	0.93%	179,689	$907,000	—	31 Mar 2022	13F
BBR PARTNERS, LLC	13F	Company	0.85%	164,041	$828,000	—	31 Mar 2022	13F
Walleye Capital LLC	13F	Company	0.83%	160,937	$813,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.79%	151,378	$764,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.78%	149,460	$755,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.56%	108,904	$550,000	—	31 Mar 2022	13F
Eagle Health Investments LP	13F	Company	0.52%	100,000	$505,000	—	31 Mar 2022	13F
MetLife Investment Management, LLC	13F	Company	0.44%	84,513	$426,791	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.42%	80,903	$409,000	—	31 Mar 2022	13F
SG Americas Securities, LLC	13F	Company	0.41%	79,097	$399,000	—	31 Mar 2022	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.38%	73,645	$372,000	—	31 Mar 2022	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.35%	67,756	$342,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.33%	63,593	$321,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.3%	58,684	$296,000	—	31 Mar 2022	13F
Erste Asset Management GmbH	13F	Company	0.28%	54,000	$289,440	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.28%	53,500	$270,000	—	31 Mar 2022	13F

Institutional Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) as of Q2 2022

As of 30 Jun 2022, Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 105,615,240 shares. The largest 10 holders included MWG Management Ltd., Apoletto Ltd, Foresite Capital Management IV, LLC, VANGUARD GROUP INC, BlackRock Inc., Alphabet Inc., PRICE T ROWE ASSOCIATES INC /MD/, MIC Capital Management UK LLP, SC CHINA HOLDING Ltd, and FMR LLC. This page lists 72 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-6

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.